These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23406550)

  • 21. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction.
    D'Andrea G; Perini F; Hasselmark L; Alecci M; Cananzi AR
    Funct Neurol; 1995; 10(2):91-8. PubMed ID: 7557557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease.
    Addad F; Chakroune T; Asma A; Abderazek F; Zohra D; Ghrissi I; Hassine M; Gamra H; Elalamy I
    Thromb Res; 2009 Feb; 123(4):640-3. PubMed ID: 18602138
    [No Abstract]   [Full Text] [Related]  

  • 24. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin.
    McQuillan A; Eikelboom JW
    N Engl J Med; 2002 May; 346(20):1589-90; author reply 1589-90. PubMed ID: 12017164
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Take an aspirin or have a drink: antecedent aspirin and moderate alcohol consumption similarly affect baseline platelet characteristics in patients with acute myocardial infarction.
    Serebruany VL; Lowry DR;
    Thromb Haemost; 2000 Nov; 84(5):933-4. PubMed ID: 11127889
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of naftidrofuryl on platelet aggregation in plasma from aspirin treated patients: an in vitro study.
    Le Dévéhat C; Khodabandehlou T; Mosnier M
    Clin Hemorheol Microcirc; 2000; 22(3):197-204. PubMed ID: 10976713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Decreased platelet aggregation during angiotensin-converting enzyme inhibitor therapy. Results of a pilot study].
    Skowasch D; Lentini S; Andrié R; Jabs A; Bauriedel G
    Dtsch Med Wochenschr; 2001 Jun; 126(24):707-11. PubMed ID: 11446026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity in platelet cyclooxygenase inhibition by aspirin in coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Palisaitis DA; Diodati JG
    Int J Cardiol; 2011 Jul; 150(1):39-44. PubMed ID: 20207433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin therapy for cancer: it is never too late.
    Jankowski JA; Limburg PJ
    Br J Cancer; 2011 Oct; 105(8):1105-6. PubMed ID: 21989214
    [No Abstract]   [Full Text] [Related]  

  • 31. Aspirin as adjuvant therapy in childhood cancer?
    Morgan G
    Br J Cancer; 2012 Jan; 106(1):240. PubMed ID: 22075944
    [No Abstract]   [Full Text] [Related]  

  • 32. Reduced platelet response to aspirin in patients with coronary artery disease and type 2 diabetes mellitus.
    Mortensen SB; Larsen SB; Grove EL; Kristensen SD; Hvas AM
    Thromb Res; 2010 Oct; 126(4):e318-22. PubMed ID: 20451957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical importance of aspirin resistance].
    Hirmerová J; Filipovský J
    Vnitr Lek; 2004 Jun; 50(6):462-9. PubMed ID: 15346640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cyclooxigenase-1 gene polymorphism and aspirin resistance].
    Bondar' TN; Kravchenko NA
    Tsitol Genet; 2012; 46(4):66-72. PubMed ID: 23074965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients.
    Nadar S; Blann AD; Lip GY
    Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical value of thrombocyte aggregation inhibitors during massive-dose estrogen therapy].
    Heinz A; Meyer WW; Hallwachs O
    Urologe A; 1984 May; 23(3):178-80. PubMed ID: 6377650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin and clopidogrel resistance-a myth or reality: an update.
    Gupta S; Gupta MM
    Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
    [No Abstract]   [Full Text] [Related]  

  • 39. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
    Markuszewski L; Rosiak M; Golanski J; Rysz J; Spychalska M; Watala C
    Basic Clin Pharmacol Toxicol; 2006 May; 98(5):503-9. PubMed ID: 16635110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.